Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study of XueBiJing Injection in Patients With Sepsis

NCT03475732 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT03475732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03475732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study of XueBiJing Injection in Patients With Sepsis
Lead sponsor
Southeast University, China
Phase
Not applicable
Overall status
Completed
Start date
March 18, 2018
Completion date
December 31, 2019
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia, sepsis, septic shock